Windtree Therapeutics Earnings Estimate

By analyzing Windtree Therapeutics' earnings estimates, investors can diagnose different trends across Windtree Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Windtree Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options. Windtree Therapeutics is projected to generate -2.27 in earnings per share on the 30th of September 2024. Windtree Therapeutics earnings estimates module stress-tests analyst consensus about projected Windtree Therapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Windtree Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Windtree Therapeutics' earnings estimates, investors can diagnose different trends across Windtree Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to gain to 0.88 in 2024, whereas Gross Profit is likely to drop (86.1 K) in 2024. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.